Abstract
The prevalence of chronic kidney disease (CKD) in the United States has increased in the last 20 years. As CKD and cardiovascular disease (CVD) are interrelated, it is important to note that trends in the prevalence of CKD and common risk factors it shares with CVD, such as hypertension and diabetes, are likely to affect the burden of both diseases in the future. While preventing and treating CVD is of high priority in the primary care setting, a major reason why CKD continues to burden the US healthcare system is because it remains under-recognized by primary care physicians and specialists, partly due to a lack of uniform screening recommendations. This paper will review the public health implications of CKD, including its epidemiology and economic burden in the United States, its risk factor commonalities with CVD, current screening recommendations and possible prevention strategies for improvement in the future. Additionally, an emphasis will be made on encouraging primary care physicians to play a more prominent role in CKD screening and primary prevention.
Keywords: Chronic kidney disease, cardiovascular disease, epidemiology, prevention, primary care, public health, screening.
Cardiovascular & Hematological Disorders-Drug Targets
Title:Chronic Kidney Disease and Cardiovascular Disease: A Focus on Primary Care
Volume: 14 Issue: 3
Author(s): Tarleen K. Singh, Vibhuti Arya and Nishanthika Navaratnarajah
Affiliation:
Keywords: Chronic kidney disease, cardiovascular disease, epidemiology, prevention, primary care, public health, screening.
Abstract: The prevalence of chronic kidney disease (CKD) in the United States has increased in the last 20 years. As CKD and cardiovascular disease (CVD) are interrelated, it is important to note that trends in the prevalence of CKD and common risk factors it shares with CVD, such as hypertension and diabetes, are likely to affect the burden of both diseases in the future. While preventing and treating CVD is of high priority in the primary care setting, a major reason why CKD continues to burden the US healthcare system is because it remains under-recognized by primary care physicians and specialists, partly due to a lack of uniform screening recommendations. This paper will review the public health implications of CKD, including its epidemiology and economic burden in the United States, its risk factor commonalities with CVD, current screening recommendations and possible prevention strategies for improvement in the future. Additionally, an emphasis will be made on encouraging primary care physicians to play a more prominent role in CKD screening and primary prevention.
Export Options
About this article
Cite this article as:
Singh K. Tarleen, Arya Vibhuti and Navaratnarajah Nishanthika, Chronic Kidney Disease and Cardiovascular Disease: A Focus on Primary Care, Cardiovascular & Hematological Disorders-Drug Targets 2014; 14 (3) . https://dx.doi.org/10.2174/1871529X14666140401115110
DOI https://dx.doi.org/10.2174/1871529X14666140401115110 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Repetitive Transient Phosphodiesterase-3 Inhibition Eliminates Non-ischemic Cardiac Remodeling and Failure
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pharmacological Management of Hypertension in the Elderly - Certitudes and Controversies
Current Pharmaceutical Design NO-NSAIDs: From Inflammatory Mediators to Clinical Readouts
Inflammation & Allergy - Drug Targets (Discontinued) To Bleed or Not to Bleed: That is the Question. The Side Effects of Apixaban
Current Drug Targets PREFACE
Cardiovascular & Hematological Disorders-Drug Targets Platelet-derived Growth Factor Receptor-beta is Differentially Regulated in Primary Mouse Pericytes and Brain Slices
Current Neurovascular Research Potential Role of Rho Kinase Inhibitors in Combating Diabetes-Related Complications Including Diabetic Neuropathy-A Review
Current Diabetes Reviews Role of the Sympathetic Nervous Activity in Hypertension-Update in 2013
Current Hypertension Reviews Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Intravitreal Triamcinolone for the Treatment of Diabetic Macular Edema
Current Diabetes Reviews Intrathecal Apelin-13 Produced Different Actions in Formalin Test and Tail-flick Test in Mice
Protein & Peptide Letters An Inflammation-related Nutrient Pattern is Associated with Both Brain and Cognitive Measures in a Multiethnic Elderly Population
Current Alzheimer Research Honey as a Source of Dietary Antioxidants: Structures, Bioavailability and Evidence of Protective Effects Against Human Chronic Diseases
Current Medicinal Chemistry Design of Second Generation Phosphodiesterase 5 Inhibitors
Current Topics in Medicinal Chemistry Carotid Intima Media Thickness and Beyond
Current Drug Targets - Cardiovascular & Hematological Disorders Editorial [Hot Topic: Nitric Oxide and Hydrogen Sulfide - Contribution of Gaseous Messengers to the Cardiovascular Control (Guest Editor: Sona Cacanyiova)]
Current Pharmaceutical Biotechnology Ponatinib: A Review of Efficacy and Safety
Current Cancer Drug Targets Chemotherapy and Targeted Agents for Elderly Women with Advanced Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery EDITOR’S PERSPECTIVE [The Challenges for Drug Development: Cytokines, Genes, and Stem Cells]
Current Neurovascular Research Low Testosterone Levels and Metabolic Syndrome in Aging Male
Current Pharmaceutical Design